Agilent reported $3.64B in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Abbott USD 29.45B 152M Sep/2026
Agilent USD 3.64B 594M Jun/2026
Align Technology USD 0 0 Dec/2024
Bio Techne USD 200M 0 Jun/2026
Bio-Rad Laboratories USD 803.1M 100K Sep/2026
Bruker USD 1.7B 111.7M Sep/2026
Charles River Laboratories USD 2.44B 176.52M Sep/2026
Danaher USD 24.39B 759M Sep/2026
Dentsply International USD 1.98B 11M Sep/2026
Edwards Lifesciences USD 598.8M 100K Sep/2026
Henry Schein USD 2.38B 82M Sep/2026
Illumina USD 1.79B 298M Sep/2026
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 14.82B 1.12B Sep/2026
Laboratory Of America USD 5.31B 607.4M Sep/2026
Mettler Toledo International USD 1.96B 81.23M Sep/2026
Myriad Genetics USD 120.7M 400K Jun/2026
OraSure Technologies USD 100K 17K Dec/2025
Quest Diagnostics USD 5.54B 92M Sep/2026
Quidel USD 2.51B 22.5M Sep/2026
Repligen USD 555.6M 4.55M Sep/2026
Revvity USD 2.63B 968K Sep/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Thermo Fisher Scientific USD 39.11B 73M Sep/2026
Waters USD 5.09B 129M Jun/2026
Zimmer Biomet Holdings USD 6.22B 61M Sep/2026